Dsm IP Assets B.v.

Nestec S.a.

Provexis Natural Products Limited

Daniel Raederstorff

Goede Schueler

Joseph Schwager

Peter Weber

Ying Wang-Schmidt

Christof Wehrli

Swen Wolfram

Thau Kiong Chung

Ann Fowler

Karin Wertz

Antoine De Saizieu

Shuen Ei Chen

Bernd Mussler

Wolfgang Schalch

Nathalie Richard

Sandra Renata Teixeira

Ying Wang Schmidt

Regina Goralczyk

Hasan Mohajeri

Claus Kilpert

Angelika Friedel

Karin Kuratli

Hubert Hug

Darko Knutti

Volker Spitzer

Daniel D'Orazio

Karine Wertz

Bernd Musselr

Goede Schüler

This invention relates to the use of the combination of 25-hydroxyvitamin D3 ('25-OH D3') and antioxidants/anti-inflammatories (ascorbic acid, vitamin E and at least one carotenoid) to make a pharmaceutical, nutraceutical or food supplement which can ameliorate various problems observed in humans connected with polycystic ovarian syndrome and cardiovascular diseases. Pharmaceuticals, nutraceuticals and food supplements containing the 25-OH D3 and antioxidants/anti-inflammatories and premixes are also provided.

Combination of 25-hydroxyvitamin D and antioxidants/anti-inflammatories for human nutraceuticals

The present invention relates to compositions comprising a water soluble tomato extract (WSTE) which may be used in maintaining cardiovascular health, lessening the risk of developing cardiovascular health problems, or reducing the likelihood of worsening an existing cardiovascular health problem in a subject exposed, or is at risk of exposure, to particulate air pollution.

Water soluble tomato extract protects against adverse effects of air pollution

This invention relates to the use of the combination of 25-hydroxyvitamin D3 ('25-OH D3') and antioxidants/anti-inflammatories (ascorbic acid, vitamin E and at least one carotenoid) to make a pharmaceutical, nutraceutical or food supplement which can ameliorate various problems observed in humans connected with polycystic ovarian 5 syndrome and cardiovascular diseases. Pharmaceuticals, nutraceuticals and food supplements containing the 25-OH D3 and antioxidants/anti-inflammatories and premixes are also provided.

Hydroxytyrosol or olive juice containing hydroxytyrosol in combination with at least one of the compounds selected from the group consisting of: creatine, coenzyme Q10, resveratrol, caffeine, carnitine, B vitamins (B1, B2, B3, B5, B6, and/or B12) and ginseng (preferably: root) extract.can be used to maintain or increase mitochondrial biogenesis in cardiac muscle, skeletal muscles, and liver tissue.

Hydroxytyrosol combinations for enhancing mitochondrial function and energy production

Compositions containing a combination of hydroxytyrosol and resveratrol or liqustilide or (&#x2212;)-epigallocatechin gallate or honokiol or genistein orbark extract or a combination of oleuropein and resveratrol or ligustilide are used to treat inflammatory disorders.

Compositions

The present invention relates to novel composition for the treatment, co-treatment or prevention of inflammatory disorders comprising an effective amount of carnosic acid 12-methylether.

Use of DIM and/or its derivatives for prevention, treatment and/or delay of age-related hearing loss in mammals.

Use of 3,3'-diindolylmethane

The present invention relates to the use of a compound as effective agent for the prevention or treatment of diabetes mellitus in a mammal. Said compounds being selected from the group of phthalide derivatives and exhibit excellent blood glucose lowering effects and thus are effective agents in the prevention or treatment of diabetes mellitus in mammals.

Use of phthalide derivatives for the treatment of type 2 diabetes mellitus

The present invention refers to carnosol and rosmanol for use (as medicament) in the treatment of a disorder connected to reduced neurotransmission, cognitive dysfunction and/or symptoms caused by headache and/or migraine, as well as to dietary and pharmaceutical compositions and their uses.

Dietary and pharmaceutical compositions containing carnosol and/or rosmanol and their uses

The present invention relates to new methoxylated aromatic compounds. It also relates to novel compositions comprising methoxylated aromatic compounds as well as to the use of these compositions as a medicament, in particular as a medicament for the treatment, co-treatment or prevention of inflammatory disorders.

Nutraceutical and pharmaceutical compositions and use thereof for the treatment, co-treatment or prevention of inflammatory disorders

Compositions comprising a catechin as found in green tea, e.g., epigallocatechin gallate, and ligand which activates the peroxisome proliferatoractivated receptor gamma (PPAR-gamma are useful for the treatment and prevention of diabetes mellitus).

Compositions for the treatment and prevention of diabetes mellitus

Compositions including, as the active ingredients, resveratrol, a derivative, metabolite or analogue thereof, and at least one additional component selected from epigallocatechin gallate (EGCG), genestein, vitamin E, polyunsaturated fatty acids, gamma-linolenic acid and vitamin K are disclosed. Also disclosed, are methods of making such compositions including admixing resveratrol, a derivative, metabolite or analogue thereof, and at least one additional component selected from EGCG, genestein, vitamin E, polyunsaturated fatty acids, gamma-linolenic acid and vitamin K are disclosed. Methods for the treatment or prevention of inflammatory diseases including administering to a subject in need of such treatment resveratrol, a derivative, metabolite or analogue thereof, in combination with at least one additional component selected from epigallocatechin gallate (EGCG), genestein, vitamin E, polyunsaturated fatty acids, gamma-linolenic acid and vitamin K are also disclosed.

Growing community of inventors

Flaxlanden, France

Daniel Raederstorff